Related Experiment Video
Updated: Jun 29, 2026

08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Bioinformatics and multiepitope DNA immunization to design rational snake antivenom
Simon C Wagstaff1, Gavin D Laing, R David G Theakston
1Alistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom. simonw@liv.ac.uk
Plos Medicine
|June 2, 2006
Summary
Researchers developed a novel DNA immunization strategy to create targeted snake antivenom. This approach identifies key toxin epitopes, leading to more specific and effective antivenom with fewer side effects than traditional methods.
Area of Science:
- * Biochemistry and Molecular Biology
- * Immunology
- * Bioinformatics
Background:
- * Snake venom is a complex mixture of proteins, making purification and characterization challenging.
- * Conventional antivenoms derived from animal sera have unknown specificities and can cause adverse reactions.
- * There is a need for rational design of toxin-targeted antivenoms.
Purpose of the Study:
- * To design a more rational, toxin-targeted antivenom using molecular sequence analysis and DNA immunization.
- * To develop a novel bioinformatic strategy for identifying immunogenic epitopes from snake venom glands.
- * To engineer a synthetic multiepitope DNA immunogen for enhanced antivenom efficacy.
Main Methods:
- * Bioinformatic analysis of an Echis ocellatus venom gland cDNA library to identify snake venom metalloproteinase (SVMP) epitopes.
- * Engineering of seven predicted SVMP epitopes into a single synthetic multiepitope DNA immunogen (epitope string).
- * Comparison of antiserum raised against the epitope string with conventional whole-venom antivenom.
Main Results:
- * The epitope string antiserum showed specificities to multiple SVMPs in Echis ocellatus and other viper venoms.
- * Antiserum cross-specifically neutralized hemorrhage induced by Echis ocellatus and Cerastes cerastes cerastes venoms.
- * Predicted in silico epitope representation was confirmed by antibody specificities.
Conclusions:
- * The study provides valuable sequence and structure/function information for viper venom hemorrhagins.
- * A new conceptual approach to toxin-specific antivenom design has been established, marking a significant advancement.
- * The methodology is adaptable for immunotherapy design against numerous, diverse, and poorly characterized targets.
Related Concept Videos
Cross-reactivity
Overview
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

